Adam Chambers appointed to board of Shuttle Pharmaceuticals; principal of Bowery Consulting

Shuttle Pharmaceuticals Holdings, Inc.

Appointment effective September 8, 2025; no family relationships with other directors/officers.
Chambers is principal of Bowery Consulting, lender under revolving loan (Feb 28, 2025) and consulting services (Mar 21, 2025).
No other material interests in transactions required to be disclosed under Item 404(a).
No arrangements or understandings under which he was appointed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.